Healthcare -
Biotechnology - NASDAQ - US
$ 25.18
-1.33 %
$ 3.16 B
Market Cap
-15.74
P/E
APLS - OTHER LONG-TERM ASSETS
Other Long-term Assets APLS - Apellis Pharmaceuticals, Inc.
77.1 M
LAST VALUE
120.85%
2 YEAR CAGR
188.57%
5 YEAR CAGR
114.59%
10 YEAR CAGR